GlassScriptPhysician profile
Jamar George Williams
NPI 1477537371
$1,034.95
in general payments reported to CMS, 2019-2025
18 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.86 · 2020: $18.68 · 2021: $29.07 · 2022: $35.04 · 2023: $164 · 2024: $268 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $359.10 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Xeris Pharmaceuticals, INC. | $70.52 | 2024-2025 | Gvoke Hypopen |
| Boston Scientific Corporation | $69.30 | 2025 | Bodyguardian |
| Glaxosmithkline, LLC. | $57.24 | 2019-2025 | Shingrix, Arexvy |
| Dexcom, INC. | $56.95 | 2022-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $54.71 | 2024-2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $50.67 | 2024-2025 | Veozah |
| Abbvie INC. | $45.22 | 2023-2024 | Vraylar |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.63 | 2025 | Xifaxan |
| Amgen INC. | $38.34 | 2023 | Evenity, Prolia, Repatha |
| Abbott Laboratories | $36.82 | 2024 | Freestyle Libre 3 |
| Pfizer INC. | $34.48 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $29.07 | 2021 | |
| Merck Sharp & Dohme LLC | $28.90 | 2023 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Janssen Pharmaceuticals, INC | $21.45 | 2024 | Xarelto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $15.55 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $14.29 | 2023 | Breztri |
| Novartis Pharmaceuticals Corporation | $13.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamar Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.